Vimarsana
Biggest News Aggregation in the World

Noam Auslander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Noam Auslander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Noam Auslander Today - Breaking & Trending Today

The Wistar Institute: Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy - Vimarsana News

The Wistar Institute: Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy

Wistar's Lieberman lab stopped inflammatory signaling and immune response in lab samplesPHILADELPHIA, PA, May 28, 2024., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D.

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors - Vimarsana News

Wistar scientists uncover a key mechanism as to how p53 suppresses tumors

The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill it.

The Wistar Institute: Wistar Scientists Discover Innate Tumor Suppression Mechanism - Vimarsana News

The Wistar Institute: Wistar Scientists Discover Innate Tumor Suppression Mechanism

Findings could benefit African Americans who possess a specific genetic variant of p53PHILADELPHIA, PA, May 04, 2023, a journal of the American Association for Cancer Research, researchers at The Wistar

Key Biomarkers for Prediction Response to Melanoma Therapy identified - Vimarsana News

Key Biomarkers for Prediction Response to Melanoma Therapy identified

Using advanced computing technology scientists at the Wistar Institute (Philadelphia) have been able to provide evidence of novel, reliable biomarkers that better predict therapy response of patients undergoing immune checkpoint inhibitor (ICI) treatment. Click to read more...

Key Markers Identify Which Melanoma Patients Respond Best to ICI Therapy - Vimarsana News

Key Markers Identify Which Melanoma Patients Respond Best to ICI Therapy

Researchers have identified key markers to help physicians predict whether or not a patient may respond positively to ...